Meridian Financial Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,534
| Closed | -$1.01M | – | 85 |
|
|
2022
Q2 | $1.01M | Buy |
3,534
+3
| +0.1% | +$861 | 0.69% | 37 |
|
|
2022
Q1 | $921K | Buy |
3,531
+133
| +4% | +$34.7K | 1.37% | 21 |
|
|
2021
Q4 | $784K | Buy |
3,398
+509
| +18% | +$117K | 0.53% | 42 |
|
|
2021
Q3 | $521K | Buy |
2,889
+62
| +2% | +$11.2K | 0.35% | 54 |
|
|
2021
Q2 | $556K | Buy |
2,827
+113
| +4% | +$22.2K | 0.38% | 52 |
|
|
2021
Q1 | $598K | Buy |
2,714
+183
| +7% | +$40.3K | 0.45% | 48 |
|
|
2020
Q4 | $599K | Buy |
+2,531
| New | +$599K | 0.46% | 43 |
|